Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Baby eczema relieving cream

A soothing and eczema technology, applied in non-active ingredients medical preparations, plant raw materials, organic active ingredients, etc., can solve the problem of hormone-dependent dermatitis, adverse reactions, and inability to apply plaster casually in babies, and achieve prevention and treatment. Eczema, no toxic side effects, good maintenance effect

Inactive Publication Date: 2020-06-30
福建百想生物科技有限公司
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When the baby suffers from eczema, parents should not apply ointment casually. Most of the eczema treatment products currently on the market are ointments with hormones or antibiotics. Although the effect is quick, it is easy to cause hormone-dependent dermatitis in the baby, which may not be suitable for the baby. , has many side effects and adverse reactions, so there is an urgent need for a mild, safe, no side effects product that can be safely used for babies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0015] In order to make the technical means, creative features, goals and effects achieved by the present invention easy to understand, the present invention will be further described below in conjunction with specific embodiments.

[0016] This embodiment provides a baby eczema soothing ointment, which is composed of the following raw materials in terms of mass percentage: 3-10% caprylic triglyceride, 3%-15% petrolatum, 5-6% borage seed oil, spermaceti Stearyth-252~5%, Cetearyl Alcohol 1-2%, Dimethicone 2-5%, Camellia Seed Oil 3-6%, Cetearyl-60.5 ~1%, Glyceryl Stearate 1~3%, PEG-100 Glyceryl Stearate 3~5%, Tocopherol 1~2%, Glycerin 3~6%, Propylene Glycol 2~5%, Colloidal Oat Flour 1-2%, panthenol 1-2%, polyacrylamide 2-4%, allantoin 0.5-1%, p-hydroxyacetophenone 1-3%, ceramide-31-3%, ceramide-12 ~4%, Ceramide-6Ⅱ1~3%, Carbomer 0.5~2%, Sodium Hydroxide 0.5~1%, Laureth-71~3%, Caprylyl Hydroxamic Acid 1~2%, Fragrance 0.05% ~0.1%, the balance is purified water.

[0017] In this ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a baby eczema relieving cream. The baby eczema relieving cream consists of the following raw material components: caprylic triglyceride, petrolatum, borage seed oil, ceteareth-25, cetearyl alcohol, polydimethylsiloxane, camellia seed oil, ceteareth-6, glycerol stearate, PEG-100 glycerol stearate, tocopherol, glycerol, propylene glycol, colloidal oat powder, panthenol, polyacrylamide, allantoin, p-hydroxyacetophenone, ceramide-3, ceramide-1, ceramide-6II, carbomer, sodium hydroxide, laureth-7, caprylohydroxamic acid, essence, and the balance of purified water. Accordingto the invention, through combined action of the components, effects of the components are effectively exerted, so that the product has the effects of resisting bacteria, diminishing inflammation, andisolating, repairing and moisturizing skins, can effectively prevent and treat the eczema, can be used to repair the treated skins, and has a better curing effect.

Description

technical field [0001] The invention relates to a baby eczema soothing ointment, which is applied in the technical field of infant skin care. Background technique [0002] Pediatric eczema, i.e. atopic dermatitis, also known as atopic dermatitis, atopic dermatitis, is a chronic, recurrent, inflammatory skin disease. The onset is more common in infants and young children, and persists to childhood and adulthood. It is clinically characterized by eczema-like rash, accompanied by severe itching, and repeated attacks. Patients or their families often have obvious "atopicity", which seriously affects the quality of life. It is mainly caused by intolerance or allergy to ingested, inhaled or contacted substances. When the baby suffers from eczema, parents should not apply ointment casually. Most of the eczema treatment products currently on the market are ointments with hormones or antibiotics. Although the effect is quick, it is easy to cause hormone-dependent dermatitis in the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/899A61K9/00A61K47/10A61P17/00A61P17/04A61P29/00A61P37/08A61K31/164A61K31/355A61K31/80
CPCA61K9/0014A61K31/164A61K31/355A61K31/80A61K36/30A61K36/82A61K36/899A61K47/10A61P17/00A61P17/04A61P29/00A61P37/08A61K2300/00
Inventor 蔡小玲郑乃斌
Owner 福建百想生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com